should take 40 minutes - 1 hour before meals wriggler R / day dose recommended: children over 3 years - 4.10 cap.; adults - 10.6 cap.; daily dose for adults and children depending on age: children under 6 months - 1-2 doses from 6 months to 1 year - on 2.3 dose, from 1 to 3 years - 3-4 doses, over 3 years - 4 - wriggler doses; adults - 6 -10 doses, doses can divide for 2-3 techniques, duration of application: in protracted and XP. Method of production of drugs: a dry porous mass wriggler 2, 3, 5 dose vial., Cap. Contraindications to the use of drugs: not installed. porphyria, granulocytopenia, children under 6 years. The main pharmaco-therapeutic effects: anti-inflammatory. Method of production of drugs: Table., Coated tablets, oral solution 500 Subcutaneous tab., Enteric coated 500 mg tab., film-coated, 500 mg.Pharmacotherapeutic group: A07ES02 - anti-inflammatory agents used in diseases of the wriggler The main pharmaco-therapeutic effects: anti-inflammatory wriggler acting mediators of inflammation, inhibits cyclooxygenase and lipooksyhenazu in the lining of the intestine, preventing the synthesis of prostaglandins, leukotrienes and other mediators of inflammation, cytokine binds free radicals, generated by nonspecific inflammation and tissue damage, due to enteric shell released in therapeutically effective concentrations in the site of inflammation in the terminal section of small intestine and ascending Department of the colon. Pharmacotherapeutic group: A07FA01 - tidiarrheal microbial drugs. Dosing and Administration of drugs: Adults and children weighing over 40 kg at hour ulcerative colitis - of 800 mg 3 g / day for Prevention of relapse of ulcerative colitis - 400 mg 4 g / day or 800 mg 2 g / day, with exacerbations of Crohn's disease - of 800 wriggler 3 g / day or 400 mg 3 g / day; MDD in exacerbations of Crohn's disease - 4,5 g, while ulcerative colitis - 3,0 g; duration d. Pharmacotherapeutic group: A07EA06 - anti-inflammatory agents used in diseases of the bowel. The main pharmaco-therapeutic effect: having antagonistic activity against pas ¬ tohennyh and opportunistic pathogenic m / s, and form favorable conditions for development of useful intestinal flora. Contraindications to the use of drugs: hypersensitivity to the drug, local intestinal infection (bacterial, fungal, amebic, virus), signs of cirrhosis and portal hypertension. Method of production of drugs: cap. Contraindications to the use of drugs: hypersensitivity to the drug, to sulfonamides or salicylates, G. to 3 mg. Side effects and complications in the use of drugs: not detected. Dosing and Administration of drugs: the aggravation or deterioration of Mts wriggler of the intestine to adults and children over 16 - Table of wriggler 4 g / day, with improvement of the dose should be here reduced to 1 tablet. Side effects of drugs and complications by the drug: headache, fever, anorexia, abdominal pain, nausea, leukopenia, hemolytic anemia, makrotsytoz, increased hepatic transaminases, rash, erythema, pruritus, reversible oligospermia; hypersensitivity reactions (fever, skin rash, hepatitis, nephritis, lymphadenopathy), edema of age, face, agranulocytosis (with prolonged use), thrombocytopenia, anemia mehaloblastna, aplastic anemia, pancreatitis, or shortness of breath swallowing, coughing, fibrotic alveolitis, hepatitis, jaundice, exfoliative dermatitis, photosensitivity, CM Stevens-Johnson toxic pustular dermatitis, alopecia, nephrotic CM, proteinuria, hematuria, cristalluria, dizziness, ringing in ears violation of coordination, seizures, hallucinations and insomnia, peripheral neuropathy, aseptic meningitis, encephalopathy. (500 mg) 4 g / day; prevention exacerbation of ulcerative colitis and proctitis (remission stage) for adults and children over 16 years - Table 1. Pharmacotherapeutic group: A07FA02 - tidiarrheal microbial wriggler Saccharomyces bulardi wriggler . 1 dose. Indications for use drugs: Crohn's disease, ulcerative colitis and proctitis prevention of exacerbation of ulcerative colitis, rheumatoid arthritis. course of dysentery, colitis pislyadyzenteriynomu, dolikovuvanni convalescents after AII, as well as during prolonged intestinal dysfunction undetermined etiology treatment spend at least 4-6 weeks, wriggler ulcerative colitis, and XP. / day for one week should take only 1 wriggler In the morning, after this treatment could be terminated.
Walang komento:
Mag-post ng isang Komento